"Thomayerova nemocnice je moderně se rozvíjející klinické centrum, kde se poskytuje specializovaná medicína na velmi vysoké úrovni a které současně poskytuje zázemí odborníkům z mnoha lékařských oborů. Naši odbornou pomoc zaměřujeme především na pediatrické obory, traumatologii, onkologii a pneumologii. Samozřejmě si udržujeme vysoký standard i v dalších klinických oborech."

During the past decade, Thomayerova nemocnice conducted 77 clinical trials. In the 10-year time frame, 77 clinical trials started and 39 clinical trials were completed, i.e. on average, 50.6% percent of trials that started reached the finish line to date. In the past 5 years, 41 clinical trials started and 31 clinical trials were completed. i.e. 75.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Thomayerova nemocnice" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Boehringer Ingelheim" with 7 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored, "Pfizer" with 7 trials sponsored and "Amgen" with 7 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Thomayerova nemocnice" #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Boston Scientific Corporation" with 2 trials as a collaborator, "Charles University, Czech Republic" with 2 trials as a collaborator and "Merck Sharp & Dohme LLC" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Thomayerova nemocnice" are "Rheumatoid Arthritis" (9 trials), "Idiopathic Pulmonary Fibrosis" (5 trials), "Renal Cell Carcinoma" (4 trials), "Breast Cancer" (3 trials) and "Crohn's Disease" (3 trials). Many other conditions were trialed in "Thomayerova nemocnice" in a lesser frequency.

Most popular intervention types in "Thomayerova nemocnice" are "Drug" (79 trials), "Biological" (7 trials), "Other" (5 trials), "Device" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "placebo" (5 trials), "Cisplatin" (4 trials), "Gemcitabine" (4 trials) and "Oxaliplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Thomayerova nemocnice" are 78 trials for "All" genders, 12 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Thomayerova nemocnice". 1 are not yet recruiting, 21 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Thomayerova nemocnice, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Thomayerova nemocnice, 0 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 5 trials that are defined as “Not Applicable".

Thomayerova nemocnice has several departments that took part in Clinical trials: "Fakultni Thomayerova Nemocnice; Onkologicke Oddeleni" - 9 trials, "Thomayerova nemocnice; Pneumologicka klinika 1.LF UK TN" - 3 trials, "Centrum kardiovaskularni prevence 1. LF UK a TN" - 2 trials